News UK plans to invest 'billions' in Essex biosecurity centre The UK government has revealed a plan to open a multibillion-pound biosecurity facility to protect the country from emerging public health threats.
News Medical chatbot firm OpenEvidence raises $210m OpenEvidence has raised $210m to expand the capabilities of its physician decision-making tool and launch a new service offering 'PhD-level' research.
News NICE relents and backs Kisqali for wide use in breast cancer Novartis' breast cancer therapy Kisqali has been cleared for NHS use in early breast cancer, an indication driving blockbuster sales of the drug.
News EVERSANA unveils new AI-powered pharmacovigilance suite EVERSANA has launched a new pharmacovigilance platform to answer the need for advanced analytics and AI in drug safety monitoring and risk management.
News Four AIs for spinal fractures can be used by NHS, says NICE AIs that detect spinal fractures during routine CT scans could help the NHS reduce hip fractures and other costly complications, says NICE.
News Bayer extends CEO contract amid 'signs of success' Bayer's chief executive Bill Anderson looks set to keep his role until nearly the decade, as his turnaround plan starts to deliver results.
R&D Treating the chronic diseases GLP-1s miss, with Laurent Auda... Prive Bio CEO Laurent Audaly spoke with pharmaphorum during the JP Morgan Healthcare conference, discussing GLP-1s in the cardiometabolic space.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.